47426-201 : Cinvanti 130 mg/18ml Intravenous Injection, Emulsion


NDC: 47426-201
Labeler: Heron Therapeutics
Product Type: Human Prescription Drug
Drug Name:  Cinvanti
Dosage Form: Intravenous Injection, Emulsion
Application #: NDA209296
Rev. Date: 


NDC Package Codes:

  • 47426-201-01: 1 VIAL, GLASS IN 1 CARTON (47426‑201‑01) > 18 ML IN 1 VIAL, GLASS

Active Ingredients:

  • Aprepitant

Dosage Strength:

  • 130 mg/18mL

Pharmaceutical Classes:

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 47426-201 QR Code

< Prev: 47426-101Next: 47426-301 >

Related Discussions:

Pantoprazole 40mg and Aprepitant 80
I am taking Pantoprazole for severe acid reflux. Yesterday I started chemotherapy for breast cancer and have been prescr... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.